Zydus Cadila receives USFDA nod for diabetes medicines

The US health authorities approved Sitagliptin for marketing, which was recommended to treat diabetes, on Monday, Drug company Zydus Cadila said. The business said its affiliate obtained preliminary clearance for its new Sitagliptin Base 25, 50 and 100 mg tablets from the US Food and Drug Administration (FDA).

In an application for authorisation to commercialise Sitagliptin bases 25, 50 and 100mg tablets, Zydus submitted their new medication application to the USFDA on 31 October 2020.   Once the first review cycle was completed on 2 September 2021, Zydus Cadila indicated that the NDA got preliminary clearance.

Zydus Cadila discovers, develops, manufactures, and markets a broad range of healthcare therapies including small molecule drugs, biologic therapeutics, and vaccines.

The group employs around 23,000 people worldwide. The group employs around 23,000 people worldwide.

 

Medically Speaking

Recent Posts

Dysautonomia: The Silent Illness Affecting Millions Globally

Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…

2 days ago

Chyawanprash: Your Ayurvedic Shield Against Cough & Cold

https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…

2 days ago

Why Winter Morning Walks (7-9 AM) Are Perfect for Your Health

Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…

2 days ago

Does Maida Stick to Your Gut? Debunking Myths and Health Risks

Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…

2 days ago

Think Twice Before Heating Packaged Milk: Hidden Risks You Should Know!

https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…

2 days ago

MENTAL HEALTH STRUGGLES: THE LONG-TERN IMPACT ON TEENAGERS

A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…

3 days ago